publications / brochures
Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy
Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage
Dissecting the idiosyncratic drug-induced liver injury (iDILI)-initiating mechanism using the individual-centric model: the role of the innate immune response
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone
Detection of idiosyncratic drug-induced liver injury (iDILI) with the GenuineSelect-TOX system
